A menopause drug commonly used to relieve symptoms such as hot flushes may also help slow the growth of breast cancer cells in postmenopausal women, according...
A self-collection device for cervical cancer screening has shown equivalent effectiveness to traditional clinic-based testing, according to new research that could help address screening gaps affecting...
A groundbreaking, cross-industry initiative designed to improve adherence to clinical guidelines in the treatment of early and metastatic breast cancer has been launched by health data company Novellia....
Scientists have found that global warming in the Middle East and North Africa is making breast, ovarian, uterine, and cervical cancer more common and more deadly. ...
Additional imaging techniques detect early stage cancers missed by mammograms in women with dense breasts, a new trial has found. In women with dense breasts (breasts...
Merck’s immunotherapy drug Keytruda (pembrolizumab) has shown a “statistically significant” survival benefit in platinum-resistant ovarian cancer, potentially offering a new treatment path for patients with few...
British medical experts are raising concerns about the underrepresentation of women in clinical studies, The Guardian reports, with male-only trials outnumbering female-focused research by 67 per cent. Healthcare...
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers. In a trial where cancers were treated...
Three women’s cancer innovators have been shortlisted for a Femtech World award. The event celebrates some of the best examples of leadership, innovation and impact in...
US regulators have approved the first at-home vaginal self-collection device for cervical cancer screening, offering women an alternative to in-clinic exams. The Teal Wand, developed by women’s...
